A human immune dysregulation syndrome characterized by severe hyperinflammation with a homozygous nonsense Roquin-1 mutation

Journal: Nature Communications

Published: 2019-10-21

DOI: 10.1038/s41467-019-12704-6

Affiliations: 34

Authors: 28

Go to article
Institutions Share
Department of Internal Medicine and Pediatrics, UGent, Belgium 0.19
Ghent University Hospital, Belgium 0.14
ANU Department of Immunology and Infectious Disease, Australia 0.06
ANU Centre for Personalised Immunology (CPI), Australia 0.06
Department of Biomedical Molecular Biology (WE14), UGent, Belgium 0.05
VIB-UGent Center for Inflammation Research (IRC), Belgium 0.05
Jeffrey Modell Diagnosis and Research Centre, UGent, Belgium 0.05
Centre for Primary Immunodeficiency (PID), UGent, Belgium 0.05
Center for Medical Genetics (CMGG), UGent, Belgium 0.04
VIB-UGent IRC Unit of Molecular Signal Transduction in Inflammation, Belgium 0.04
Department of Applied Mathematics, Computer Science and Statistics, UGent, Belgium 0.04
VIB-UGent IRC Unit of Data Mining and Modeling for Biomedicine, Belgium 0.04
Research Unit Molecular Immune Regulation (AMIR), HMGU, Germany 0.02
Institute for Immunology, LMU, Germany 0.02
Biomedical Center München (BMC), LMU, Germany 0.02
China–Australia Centre for Personalised Immunology, China 0.02
VIB BioImaging Core, Belgium 0.02
ANU Australian Phenomics Facility, Australia 0.02
ANU John Curtin School of Medical Research (JCMSR), Australia 0.02
VIB Flow Core, Belgium 0.01
VIB-UGent IRC Unit for Immunoregulation and Mucosal Immunology, Belgium 0.01
Department of Pulmonary Medicine, Erasmus MC, Netherlands 0.01
Ablynx N.V., Belgium 0.01